Thus, IMAS represents a person-level metric that captures baseline medication-taking behaviour across therapeutic classes and predicts both medication adherence as well as health outcomes. Our analysis suggests that medication-taking behaviour represents a broader patient-level phenomenon manifesting consistently across medications, suggesting its potential for personalised interventions in clinical practice and more efficient public health strategies and policies.
Mooses et al. (Mon,) studied this question.